HLB Life Science Co., Ltd. (KOSDAQ:067630)
2,290.00
-60.00 (-2.55%)
Nov 18, 2026, 3:30 PM KST
HLB Life Science Market Cap
HLB Life Science has a market cap or net worth of 279.03 billion as of November 17, 2026. It is the 19,979th most valuable company in the world and the 614th biggest in South Korea. Its market cap has decreased by 49.89% in one year.
Market Cap
279.03B
Enterprise Value
404.93B
Revenue
55.99B
Global Rank
Country Rank
#614 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2008, HLB Life Science's market cap has increased from 12.28B to 279.03B, an increase of 2,171.73%. That is a compound annual growth rate of 18.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 279.03B | -40.90% |
| Dec 30, 2025 | 472.16B | -61.28% |
| Dec 30, 2024 | 1.22T | 4.61% |
| Dec 28, 2023 | 1.17T | 8.14% |
| Dec 29, 2022 | 1.08T | -9.34% |
| Dec 30, 2021 | 1.19T | -7.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.18T |
| Celltrion | 48.09T |
| ALTEOGEN | 11.94T |
| Samsung Epis Holdings | 8.89T |
| MEDIPOST | 297.05B |
| Orum Therapeutics | 293.88B |
| Samyang Biopharm | 293.72B |
| WON TECH | 290.28B |